184 related articles for article (PubMed ID: 31850803)
21. Dysregulated Smooth Muscle Cell BMPR2-ARRB2 Axis Causes Pulmonary Hypertension.
Wang L; Moonen JR; Cao A; Isobe S; Li CG; Tojais NF; Taylor S; Marciano DP; Chen PI; Gu M; Li D; Harper RL; El-Bizri N; Kim YM; Stankunas K; Rabinovitch M
Circ Res; 2023 Mar; 132(5):545-564. PubMed ID: 36744494
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes.
Steinbusch LK; Dirkx E; Hoebers NT; Roelants V; Foretz M; Viollet B; Diamant M; van Eys G; Ouwens DM; Bertrand L; Glatz JF; Luiken JJ
J Mol Cell Cardiol; 2013 Feb; 55():165-73. PubMed ID: 23159540
[TBL] [Abstract][Full Text] [Related]
23. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes.
Angin Y; Steinbusch LK; Simons PJ; Greulich S; Hoebers NT; Douma K; van Zandvoort MA; Coumans WA; Wijnen W; Diamant M; Ouwens DM; Glatz JF; Luiken JJ
Biochem J; 2012 Nov; 448(1):43-53. PubMed ID: 22780108
[TBL] [Abstract][Full Text] [Related]
24. Novel Advances in Modifying BMPR2 Signaling in PAH.
Dannewitz Prosseda S; Ali MK; Spiekerkoetter E
Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33374819
[TBL] [Abstract][Full Text] [Related]
25. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
[TBL] [Abstract][Full Text] [Related]
26. Fibroblast growth factor 21 protects against lipotoxicity-induced pancreatic β-cell dysfunction via regulation of AMPK signaling and lipid metabolism.
Xie T; So WY; Li XY; Leung PS
Clin Sci (Lond); 2019 Oct; 133(19):2029-2044. PubMed ID: 31654570
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary vascular effect of insulin in a rodent model of pulmonary arterial hypertension.
Trammell AW; Talati M; Blackwell TR; Fortune NL; Niswender KD; Fessel JP; Newman JH; West JD; Hemnes AR
Pulm Circ; 2017; 7(3):624-634. PubMed ID: 28704134
[TBL] [Abstract][Full Text] [Related]
28. Phenotypically Silent Bone Morphogenetic Protein Receptor 2 Mutations Predispose Rats to Inflammation-Induced Pulmonary Arterial Hypertension by Enhancing the Risk for Neointimal Transformation.
Tian W; Jiang X; Sung YK; Shuffle E; Wu TH; Kao PN; Tu AB; Dorfmüller P; Cao A; Wang L; Peng G; Kim Y; Zhang P; Chappell J; Pasupneti S; Dahms P; Maguire P; Chaib H; Zamanian R; Peters-Golden M; Snyder MP; Voelkel NF; Humbert M; Rabinovitch M; Nicolls MR
Circulation; 2019 Oct; 140(17):1409-1425. PubMed ID: 31462075
[TBL] [Abstract][Full Text] [Related]
29. Raf/ERK drives the proliferative and invasive phenotype of BMPR2-silenced pulmonary artery endothelial cells.
Awad KS; Elinoff JM; Wang S; Gairhe S; Ferreyra GA; Cai R; Sun J; Solomon MA; Danner RL
Am J Physiol Lung Cell Mol Physiol; 2016 Jan; 310(2):L187-201. PubMed ID: 26589479
[TBL] [Abstract][Full Text] [Related]
30. High density lipoprotein (HDL) reverses palmitic acid induced energy metabolism imbalance by switching CD36 and GLUT4 signaling pathways in cardiomyocyte.
Wen SY; Velmurugan BK; Day CH; Shen CY; Chun LC; Tsai YC; Lin YM; Chen RJ; Kuo CH; Huang CY
J Cell Physiol; 2017 Nov; 232(11):3020-3029. PubMed ID: 28500736
[TBL] [Abstract][Full Text] [Related]
31. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
[TBL] [Abstract][Full Text] [Related]
32. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
33. Globular and full-length forms of adiponectin mediate specific changes in glucose and fatty acid uptake and metabolism in cardiomyocytes.
Palanivel R; Fang X; Park M; Eguchi M; Pallan S; De Girolamo S; Liu Y; Wang Y; Xu A; Sweeney G
Cardiovasc Res; 2007 Jul; 75(1):148-57. PubMed ID: 17499232
[TBL] [Abstract][Full Text] [Related]
34. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
John A; Kizhakkedath P; Al-Gazali L; Ali BR
Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
[TBL] [Abstract][Full Text] [Related]
35. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
[TBL] [Abstract][Full Text] [Related]
36. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
[TBL] [Abstract][Full Text] [Related]
37. Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathway.
Parra V; Verdejo HE; Iglewski M; Del Campo A; Troncoso R; Jones D; Zhu Y; Kuzmicic J; Pennanen C; Lopez-Crisosto C; Jaña F; Ferreira J; Noguera E; Chiong M; Bernlohr DA; Klip A; Hill JA; Rothermel BA; Abel ED; Zorzano A; Lavandero S
Diabetes; 2014 Jan; 63(1):75-88. PubMed ID: 24009260
[TBL] [Abstract][Full Text] [Related]
38. BMPR2 gene therapy for PAH acts via Smad and non-Smad signalling.
Harper RL; Reynolds AM; Bonder CS; Reynolds PN
Respirology; 2016 May; 21(4):727-33. PubMed ID: 26809239
[TBL] [Abstract][Full Text] [Related]
39. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
[TBL] [Abstract][Full Text] [Related]
40. A potential role for insulin resistance in experimental pulmonary hypertension.
West J; Niswender KD; Johnson JA; Pugh ME; Gleaves L; Fessel JP; Hemnes AR
Eur Respir J; 2013 Apr; 41(4):861-71. PubMed ID: 22936709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
